|
|
|
Over the years, B&H Consulting Services, Inc. has
supported many clients with diverse needs. Prior to beginning a project, we
assess a company’s needs to gain an understanding of how B&H can best help
accomplish the task at hand. As a service company, we are committed to
understanding and meeting each client’s needs.
The following are just
a few examples of projects completed by B&H
|
|
Chemistry, Manufacturing and Controls
- Manage the
coordination, technical writing and compilation of Chemistry,
Manufacturing and Controls (CMC) documentation for both human and
veterinary applications submitted to United States, Canadian and European
Health Authorities investigation al and marketing applcations, ensuring
that all information was accurate and complete, meeting currently
acceptable standards, (i.e., ICH, 21 CFR, etc.)
- Worked with CMC
teams to compile amendments, supplements and variations to global
regulatory submissions
- Contracted and
monitored analytical methods development studies on behalf of client
companies
|
|
CMC Queries
- Addressed Chemistry,
Manufacturing and Controls (CMC) queries from Health Authorities around
the world
- Drafted responses
and forwarded to CMC team for review and approval
- Worked with company
affiliates to successfully submit timely responses to queries, resulting
in marketing approvals
|
|
Annual Reports for Investigational New Drug (IND) Applications and New Drug
Applications (NDA)
- Established policies
and procedures for the submission of over 110 IND and NDA Annual Reports
each year. For each annual report, activities include
- issuance of the
“Call for Information”
- collection, review
and verification of source data for accuracy
- preparation and
circulation of a draft report for comments and approval
- revisions to the
annual report as necessary
- preparation of the
appropriate FDA form and cover letter
- issuance of the
final annual report, FDA form and cover letter for final review and
signature for FDA submission and internal distribution
|
|
Initial Filing of IND
- Filed initial
Investigational New Drug (IND) applications
- Provided guidance on
the content and format of the initial applications
- Reviewed source
documents to ensure all items of the IND were accurate and complete,
meeting requirements of 21CFR 312.23
- Prepared and
collated documents to meet FDA’s requirements, as well as B&H standards
and the clients’ internal requirements
- Volumized,
paginated, and created an overall Table of Contents for the IND, and
prepared the cover memo and FDA Form 1571 for inclusion in the submission
|
|
Regulatory Affairs Support
- Worked on-site at
clients’ locations; reviewed and compiled documentation for submissions,
prepared cover letters and corresponding required FDA forms; coordinated
all activities related to photocopying, pagination and submission.
- Represented non-US
companies as United States Agent to FDA
- Compiled and filed
all information and protocol amendments, safety reports, annual reports
and general correspondence to ensure compliance with all FDA regulations
- Acted as liaison
with FDA on behalf of client and provided regulatory strategies for issues
and questions that arose
- Assisted with
drafting core data sheets, USPI and SmPCs
- Assisted clients
through the Mutual Recognition Procedure (MRP)
- Requested meetings
with FDA; prepared “Briefing Packages” submitted to FDA in advance of
meetings.
|
|
Annual Registrations, State Registrations, Drug Product Listings
- Submitted
applications for assignment of a Labeler Code for a new private label
distributor
- Prepared the
necessary forms for registration of Drug Establishment (Form FDA 2656) and
Drug Product Listings (Form FDA 2657)
- Interacted with FDA
to ensure submission of accurate documentation
- Completed state
registrations, ensuring successful distribution of product
|
|
|
|
|
|